Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2011 AND VI 10 AND IP 6
Results: 24
1
2
Deal watch: Is deal-making becoming more difficult?
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 404, doi. 10.1038/nrd3464
- By:
- Publication type:
- Article
3
Anticancer drugs: Now get out of that....
- Published in:
- 2011
- By:
- Publication type:
- journal article
4
Mining for therapeutic gold.
- Published in:
- 2011
- By:
- Publication type:
- journal article
5
Sepsis: DAMPening inflammation.
- Published in:
- 2011
- By:
- Publication type:
- journal article
6
Reflections on the Innovative Medicines Initiative.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
7
An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
- Published in:
- 2011
- By:
- Publication type:
- commentary
8
Data exclusivity for biologics.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
9
In brief.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 416, doi. 10.1038/nrd3472
- Publication type:
- Article
10
US academic drug discovery.
- Published in:
- 2011
- By:
- Publication type:
- journal article
11
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 403, doi. 10.1038/nrd3475
- Publication type:
- Article
12
The productivity crisis in pharmaceutical R&D.
- Published in:
- 2011
- By:
- Publication type:
- journal article
13
The long march of antisense.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 401, doi. 10.1038/nrd3474
- By:
- Publication type:
- Article
14
Richard Bergström.
- Published in:
- 2011
- Publication type:
- Interview
15
Cancer: Lipoxygenase makes a leaky tumour.
- Published in:
- 2011
- By:
- Publication type:
- journal article
16
Could pharma open its drug freezers?
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
17
Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 404, doi. 10.1038/nrd3465
- Publication type:
- Article
18
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
- Published in:
- 2011
- By:
- Publication type:
- journal article
19
Autoimmune disease: Blocking the drivers.
- Published in:
- 2011
- By:
- Publication type:
- journal article
20
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 395, doi. 10.1038/nrd3460
- Publication type:
- Article
21
Mood disorders: Small-molecule neurotrophin antagonist reduces anxiety.
- Published in:
- 2011
- By:
- Publication type:
- journal article
22
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
23
Ipilimumab.
- Published in:
- 2011
- By:
- Publication type:
- journal article
24
Court refuses to hurry generic Lipitor decision.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 406, doi. 10.1038/nrd3476
- By:
- Publication type:
- Article